Jaguar Health, Inc. 8-K

What Happened
Jaguar Health, Inc. (JAGX) filed an 8-K (Item 8.01) disclosing that it paid a special one-time dividend of 0.1 share of Series O Convertible Preferred Stock per eligible common share on March 4, 2026 (recorded as of March 2, 2026), with those amounts retroactively adjusted for a 1-for-35 reverse stock split effective April 30, 2026. On June 25, 2026 at 12:00 p.m. Eastern Time, all outstanding Series O Preferred Stock and all Series O Preferred Stock issuable upon exercise of certain eligible warrants automatically converted into Common Stock at a conversion ratio of 3.209 common shares per Series O preferred share. Immediately after the conversion there were 4,857,211 shares of Common Stock issued and outstanding.

Key Details

• Special dividend paid March 4, 2026: one-tenth (0.1) of a share of Series O Preferred Stock per eligible common share (based on ~354,836 common shares plus 68,593 warrant-linked shares, adjusted for the 1-for-35 reverse split).
• Conversion date/time: June 25, 2026 at 12:00 p.m. ET. Conversion ratio: 3.209 common shares per Series O preferred share.
• Shares outstanding after conversion: 4,857,211 common shares.
• Warrants: holders of the Eligible Warrants are entitled, upon exercise, to receive up to 839,000 shares of Common Stock (68,593 Warrant Shares + 770,407 Conversion Shares).

Why It Matters
The filing documents the elimination of the Series O preferred class through automatic conversion and shows the current common share count (4.86 million) immediately after conversion. It also identifies up to 839,000 additional common shares that could be issued if the Eligible Warrants are exercised, which is a concrete source of potential dilution for current common shareholders. Investors should note these changes to the company’s share count and capital structure when assessing ownership percent, voting power, and per-share metrics.